MERTK and retinitis pigmentosa: Indeed, AAV-mediated correction of retinitis pigmentosa (RP) due to mutations in MERTK (RP38), which like RPE65 is expressed in the RPE, has also been relied to the clinic after extensive pre-clinical studies.